GPX4 and colorectal carcinoma: In the context of digestive system tumors, such as CRC, the mechanisms are diverse: in SW-480 cells, curcumin inhibits the JNK pathway, leading to GPX4 and FTH1 downregulation and ACSL4 upregulation.